Capital World Investors Seres Therapeutics, Inc. Transaction History

Capital World Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $5.72 Million - $7.91 Million	-827,810 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $1.56 Million - $2.37 Million	-212,000 Reduced 20.39%	827,810 $6.08 Million
Q4 2017 Feb 14, 2018	SELL	$9.15 - $12.64 $3.72 Million - $5.14 Million	-406,505 Reduced 28.11%	1,039,810 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $18.5 Million - $24.4 Million	1,446,315	1,446,315 $23.2 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $110M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.